| Literature DB >> 34557843 |
Daniel Paul Fudulu1, Arnaldo Dimagli1, Lauren Dixon1, Manraj Sandhu1, Lucia Cocomello1, Gianni D Angelini1, Umberto Benedetto1.
Abstract
BACKGROUND: Several studies have suggested a variation of myocardial tolerance to ischaemia depending on the daytime of surgery. To test this hypothesis, we conducted a three-level analysis: metaanalysis, national patient-level dataset analysis and a post-hoc trial analysis.Entities:
Year: 2021 PMID: 34557843 PMCID: PMC8454590 DOI: 10.1016/j.lanepe.2021.100140
Source DB: PubMed Journal: Lancet Reg Health Eur ISSN: 2666-7762
Fig. 1Forrest plot of Odds Ratios of Myocardial Infarction in patients undergoing pm vs surgery t am surgery. Abbreviations: AVR- Aortic valve replacement; CABG – coronary artery by-pass grafting; PSM – propensity matched study; RCT – srandomised controlled trial.
Fig. 2Forrest plot of Odds Ratios of 30-day mortality in patients undergoing pm vs am surgery. Abbreviations: AVR- Aortic valve replacement; CABG – coronary artery by-pass grafting; PSM – propensity matched study; RCT – srandomised controlled trial.
Isolated AVR cohort baseline characteristics
| Characteristic | AM | PM | P value |
|---|---|---|---|
| Number of patients | 15737 | 11490 | |
| Age imputed | 69.14 (11.96) | 70.06 (11.14) | <0.001 |
| Female | 6590 (41.9) | 4891 (42.6) | 0.259 |
| Chronic pulmonary disease | 1582 (10.1) | 1143 (9.9) | 0.791 |
| Extracardiac arteriopathy | 976 (6.2) | 609 (5.3) | 0.002 |
| Diabetes | 597 (3.8) | 402 (3.5) | 0.213 |
| Previous cardiac surgery | 1268 (8.1) | 388 (3.4) | <0.001 |
| Creatinine >200 µmol/l | 229 (1.5) | 119 (1.0) | 0.003 |
| Moderate LV | 2638 (16.8) | 1690 (14.7) | <0.001 |
| Poor LV | 698 (4.4) | 421 (3.7) | 0.002 |
| Recent MI | 263 (1.7) | 154 (1.3) | 0.032 |
| Pulmonary hypertension | 2638 (16.8) | 1690 (14.7) | <0.001 |
| Index of Multiple Deprivation Decile | 698 (4.4) | 421 (3.7) | 0.002 |
| Death | 264 (1.7) | 146 (1.3) | 0.008 |
Isolated CABG cohort baseline characteristics
| Characteristic | AM | PM | P value |
|---|---|---|---|
| Number of patients | 45999 | 32233 | |
| Age imputed | 66.26 (10.33) | 66.27 (10.14) | 0.905 |
| Female | 8684 (18.9) | 5889 (18.3) | 0.032 |
| Chronic pulmonary disease | 3838 (8.3) | 2712 (8.4) | 0.737 |
| Extracardiac arteriopathy | 5247 (11.4) | 3673 (11.4) | 0.969 |
| Diabetes | 1505 (3.3) | 952 (3.0) | 0.013 |
| Previous cardiac surgery | 612 (1.3) | 343 (1.1) | 0.001 |
| Creatinine > >200 µmol/l | 735 (1.6) | 524 (1.6) | 0.783 |
| Moderate LV | 10570 (23.0) | 7112 (22.1) | 0.003 |
| Poor LV | 1859 (4.0) | 1227 (3.8) | 0.101 |
| Recent MI | 15462 (33.6) | 9916 (30.8) | <0.001 |
| Pulmonary hypertension | 6943 (15.1) | 5293 (16.4) | <0.001 |
| Index of Multiple Deprivation Decile | 5.56 (2.85) | 5.48 (2.84) | <0.001 |
| Deaths | 534 (1.2) | 335 (1.0) | 0.117 |
Results of generalised linear mixed model (binomial) for the primary endpoint (mortality) among patients undergoing isolated AVR and CABG.
| AVR | CABG | |||||
|---|---|---|---|---|---|---|
| Predictors | Odds Ratios | CI | P | Odds Ratios | CI | p |
| Intercept | 0.00 | 0.00 – 0.00 | 0.00 | 0.00 – 0.00 | ||
| Age imputed | 1.04 | 1.03 – 1.05 | 1.06 | 1.05 – 1.07 | ||
| Female | 1.54 | 1.24 – 1.93 | 1.60 | 1.35 – 1.89 | ||
| Chronic pulmonary disease | 2.08 | 1.57 – 2.76 | 1.62 | 1.32 – 1.99 | ||
| Extracardiac arteriopathy | 1.44 | 1.00 – 2.08 | 0.052 | 1.82 | 1.52 – 2.17 | |
| NDD | 1.28 | 0.78 – 2.12 | 0.328 | 1.52 | 1.11 – 2.07 | |
| Previous cardiac surgery | 3.14 | 2.31 – 4.26 | 4.01 | 2.81 – 5.71 | ||
| Creatinine>200 µmol/l | 4.23 | 2.52 – 7.10 | 4.12 | 3.09 – 5.50 | ||
| Moderate LV | 1.58 | 1.21 – 2.05 | 2.17 | 1.67 – 2.84 | ||
| Poor LV | 1.81 | 1.16 – 2.83 | 1.70 | 1.31 – 2.20 | ||
| Recent MI | 1.01 | 0.47 – 2.18 | 0.979 | 1.68 | 1.42 – 1.98 | |
| Pulmonary hypertension | 2.01 | 1.57 – 2.57 | 1.17 | 0.93 – 1.47 | 0.177 | |
| Index of Multiple Deprivation Decile | 0.97 | 0.94 – 1.01 | 0.183 | 0.97 | 0.94 – 0.99 | |
| Surgery in the pm | 0.82 | 0.65 – 1.03 | 0.094 | 0.94 | 0.81 – 1.09 | 0.425 |
| σ2 | ||||||
| τ00 hospital | 0.07 | 0.07 | ||||
| ICC | 0.02 | 0.02 | ||||
| N hospital | 32 | 34 | ||||
| Observations | 22880 | 68368 | ||||
| Marginal R2 / Conditional R2 | 0.145 / 0.164 | 0.200 / 0.216 | ||||
Fig. 3Cardiac Troponin I release in the am vs pm surgery cohorts at the seven-time points (hours post-reperfusion). Data are summarised as mean±SEM.
Fig. 4ATP/AMP (A), ATP/ADP (B) and cardiomyocytes energy charge (C) in the am and pm myocardial biopsies taken from left and right ventricle, pre-and post-reperfusion in 88patients undergoing AVR (N=23) or CABG (N=65). Data are summarised as mean±SEM. Abbreviations: Pre- LV: left ventricle biopsy pre-reperfusion, Post- LV: left ventricle biopsy post-reperfusion; Pre-RV: right ventricle biopsy pre-reperfusion; Post- RV: right ventricle biopsy post-reperfusion